These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 35703190)

  • 1. Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression.
    Tang B; Zhang Q; Liu K; Huang Y
    Bioengineered; 2022 May; 13(5):13829-13848. PubMed ID: 35703190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircFNDC3B knockdown restrains the progression of oesophageal squamous cell carcinoma through miR-214-3p/CDC25A axis.
    Wang J; Li X; Duan C; Jia Y
    Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1209-1220. PubMed ID: 36184488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ-FNDC3B Functions as an Oncogenic Factor in Esophageal Squamous Cell Carcinoma via Upregulating MYO5A by Absorbing miR-136-5p and miR-370-3p.
    Zhang Y; Xiong W; Yang C; Li P; Tong H
    Biochem Genet; 2023 Oct; 61(5):1917-1936. PubMed ID: 36884165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.
    Song D; Ye Z; Chen F; Zhan L; Sun X
    BMC Cancer; 2023 Sep; 23(1):821. PubMed ID: 37667251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0005231 promotes the progression of esophageal squamous cell carcinoma via sponging miR-383-5p and regulating KIAA0101.
    Sun Z; Zhang S; Zhang N; Wang J; Wang J; Liu J
    Thorac Cancer; 2022 Jun; 13(12):1751-1762. PubMed ID: 35524161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
    Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
    J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA circ_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis.
    Yang G; Zhang Y; Lin H; Liu J; Huang S; Zhong W; Peng C; Du L
    Bioengineered; 2022 Apr; 13(4):10578-10593. PubMed ID: 35440286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA PDE3B regulates tumorigenicity via the miR-136-5p/MAP3K2 axis of esophageal squamous cell carcinoma.
    Yue W; Ye Y; Chen B; Wu D; Wang H; Hui G
    Histol Histopathol; 2023 Sep; 38(9):1029-1041. PubMed ID: 36533720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F; Sun Z; Wang D; Du T
    BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ_0006948 Promotes Esophageal Squamous Cell Carcinoma Progression by Regulating microRNA-3612/LASP1 Axis.
    Tang R; Zhou Q; Xu Q; Lu L; Zhou Y
    Dig Dis Sci; 2022 Jun; 67(6):2158-2172. PubMed ID: 34024023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircLPAR3 knockdown suppresses esophageal squamous cell carcinoma cell oncogenic phenotypes and Warburg effect through miR-873-5p/LDHA axis.
    Cheng Y; Ma Z; Liu S; Yang X; Li S
    Hum Exp Toxicol; 2022; 41():9603271221143695. PubMed ID: 36484173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal circEPB41L2 serves as a sponge for miR-21-5p and miR-942-5p to suppress colorectal cancer progression by regulating the PTEN/AKT signalling pathway.
    Jiang Z; Hou Z; Li L; Liu W; Yu Z; Chen S
    Eur J Clin Invest; 2021 Sep; 51(9):e13581. PubMed ID: 34022068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.
    Xiao Z; Feng X; Zhou Y; Li P; Luo J; Zhang W; Zhou J; Zhao J; Wang D; Wang Y; Tian Z; Zhao X
    Int J Nanomedicine; 2023; 18():95-114. PubMed ID: 36636641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircGFPT1 regulates the growth and apoptosis of esophageal squamous cell carcinoma through miR-142-5p/HAX1 axis.
    Feng Z; Zhang T; Cheng S; Yin X; Zhou Y
    Gen Thorac Cardiovasc Surg; 2024 Jan; 72(1):41-54. PubMed ID: 37455293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
    Shi Z; Jiang T; Cao B; Sun X; Liu J
    Exp Cell Res; 2022 Mar; 412(2):113033. PubMed ID: 35041823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
    Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
    Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.